Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» migraines
migraines
Allergan's NDA for Migraine Med With Novel Mechanism of Action Accepted by FDA
BioSpace
Tue, 03/19/19 - 10:29 am
Allergan
migraines
ubrogepant
FDA
Biohaven is betting hundreds of millions it can hustle ahead of rivals in a blockbuster race. A quick M&A deal could pay off backers big time
Endpoints
Mon, 03/18/19 - 12:13 pm
Biohaven
migraines
rimegepant
Lilly claims fast FDA review for Emgality in cluster headache
Pharmaforum
Tue, 03/5/19 - 11:55 am
Eli Lilly
migraines
CGRP blockers
Emgality
episodic cluster headache
Even with new competition, Botox can hold its own in growing migraine field: Allergan executives
Fierce Pharma
Thu, 01/31/19 - 11:49 am
Allergan
Botox
Amgen
Eli Lilly
Teva Pharmaceuticals
migraines
CVS to cover migraine drugs from Teva, Lilly; excludes Amgen
Reuters
Sat, 01/26/19 - 11:56 am
CVS Health
migraines
Amgen
Teva Pharmaceutical
Eli Lilly
Aimovig
Ajovy
Emgality
11 innovative medical devices you need to know from 2018
Medical Design and Outsourcing
Sun, 01/20/19 - 03:25 pm
devices
Cerebrotech Visor
stroke
blood glucose monitoring
migraines
diagnostics
mobile apps
neurodegenerative disease
spectrometry
Can Botox hang with CGRP in migraine? Allergan says yes; analysts are skeptical
Fierce Pharma
Mon, 01/14/19 - 11:11 am
Allergan
Botox
migraines
CGRP blockers
Amgen
Novartis
Aimovig
Teva Pharmaceutical
Ajovy
Eli Lilly
Emgality
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
Fri, 01/11/19 - 08:18 pm
NICE
UK
Amgen
Novartis
migraines
Aimovig
Don't fret about Lilly's 3rd-to-market start in CGRP, exec says. It's got big plans in migraine and pain, too
Fierce Pharma
Wed, 01/9/19 - 09:38 am
Eli Lilly
Emgality
migraines
CGRP blockers
Teva reports positive results for fremanezumab in phase IIIb migraine trial
Pharmaceutical Business Review
Tue, 12/18/18 - 10:14 am
Teva Pharmaceutical
migraines
clinical trials
fremanezumab
Biohaven's orally dissolving tablet meets in Phase III for acute migraine
BioCentury
Mon, 12/3/18 - 06:01 pm
Biohaven
migraines
clinical trials
BHV3000-303
Biotech Eli Lilly files for FDA approval of migraine drug lasmiditan
Fierce Biotech
Wed, 11/14/18 - 04:50 pm
Eli Lilly
migraines
FDA
Lasmiditan
Teva slumps after Express Scripts funds migraine rivals in US
Pharmaforum
Thu, 10/18/18 - 11:28 am
PBMs
Teva Pharmaceutical
migraines
Ajovy
Express Scripts
Eli Lilly
Amgen
Express Scripts covers Amgen, Lilly migraine therapies, excludes Teva drug
Yahoo/Reuters
Wed, 10/17/18 - 09:22 am
Express Scripts
PBMs
migraines
Eli Lilly
Amgen
Teva Pharmaceutical
Emgality
Aimovig
Ajovy
Three new drugs will compete fiercely to revolutionize migraine treatment — with identical $6,900 price tags
Marketwatch
Fri, 09/28/18 - 12:32 pm
migraines
Eli Lilly
Emgality
Teva Pharmaceutical
Ajovy
Amgen
Novartis
Aimovig
Lilly’s Emgality nabs third-to-market migraine nod, but aims to be 'treatment of choice' in CGRP
Fierce Pharma
Thu, 09/27/18 - 11:25 pm
Eli Lilly
Emgality
migraines
The worst seems over for Teva
GoinPharma
Tue, 09/18/18 - 10:18 pm
Teva Pharmaceutical
Ajovy
migraines
Teva wins much-needed US approval of migraine drug
Biopharma Dive
Sat, 09/15/18 - 12:09 am
Ajovy
Teva Pharmaceutical
migraines
Aimovig launch bolsters hopes for blockbuster sales
Biopharma Dive
Tue, 08/21/18 - 10:06 am
Aimovig
Amgen
Novartis
migraines
Teva confident migraine drug will launch this year despite new manufacturing woes
Biopharma Dive
Tue, 08/7/18 - 08:45 pm
Teva Pharmaceutical
fremanezumab
migraines
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »